Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The aim of this study was to determine whether tumor size, MRS parameters and apparent diffusion coefficient (ADC) measurements could be applied to predict pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC). Ninety patients with breast cancer (median size, 4.5 cm; range, 1.6–9.5 cm) were evaluated with single‐voxel 1 H MRS and dynamic contrast‐enhanced MRI. Diffusion‐weighted imaging was performed in 41 of these patients using a 1.5‐T scanner before and after completion of NAC. Pre‐ and post‐treatment measurements and changes in tumor size, MRS parameters [absolute and normalized total choline‐containing compound (tCho) integral and tCho signal‐to‐noise ratio (SNR)] and ADCs in pCR versus non‐pCR were compared using the nonparametric Mann–Whitney test. Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic performance of each parameter. After NAC, 30 patients (33%) showed pCR and 60 (67%) showed non‐pCR. At pretreatment, ADC was the only significant parameter in differentiating between pCR and non‐pCR [(0.83 ± 0.05) × 10–3 versus (0.97 ± 0.14) × 10–3 mm 2/s] (p = 0.014). Post‐treatment measurements after completion of NAC and changes in tumor size (both p < 0.001), MRS parameters (p = 0.027 and p = 0.020 for absolute tCho integral, p = 0.036 and p = 0.023 for normalized tCho integral, and p = 0.032 and p = 0.061 for tCho SNR) and ADC (p = 0.003 and p < 0.001) were significantly different between the pCR and non‐pCR groups, except for changes in tCho SNR. In ROC analysis, the areas under the ROC curve (AUCs) of 0.63–0.73 were obtained for tumor size and MRS parameters. AUCs for pre‐ and post‐treatment ADC and changes in ADC were 0.75, 0.80 and 0.96, respectively. The optimal cut‐off of the percentage change in ADC for predicting pCR was 40.7%, yielding 100% sensitivity and 91% specificity. Patients with pCR showed significantly lower pretreatment ADCs than those with non‐pCR. The change in ADC after NAC was the most accurate predictor of pCR. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789 · cited 2×
“(6) In the case of no residual enhancement after NAC, it was very difficult to determine the original tumor location.”
Background
Cited by
Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., & Wildberger, J. E. (2013) · Insights into Imaging · doi:10.1007/s13244-013-0219-y · Cited by 237
“Only one study evaluated the potential of MR spectroscopy parameters (total cholinecontaining compounds, tCho) and reported a sensitivity of 53 % and a specificity of 70 % [43].”
BackgroundInfluentialDiffusion MRI of the breast: Current status and future directions
Iima, M., Honda, M., Sigmund, E. E., Ohno Kishimoto, A., Kataoka, M., & Togashi, K. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26908 · Cited by 187
“The usefulness of pretreatment ADC for predicting clinical response(45,56,58,63) has been reported; however, there is no consensus on its ability to predict pCR.(57,59,64) Some studies have reported the utility of ADC early in treatment for detecting pCR(42,47,49,61,65) or clinical response.”
BackgroundResultCarlier, P. G., Marty, B., Scheidegger, O., Loureiro de Sousa, P., Baudin, P.-Y., Snezhko, E., & Vlodavets, D. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-160145 · Cited by 186
“A positive effect of enzyme replacement therapy on lower limb muscle volume was observed in Pompe patients already after 6 months of treatment [204].”
BackgroundGu, Y.-L., Pan, S.-M., Ren, J., Yang, Z.-X., & Jiang, G.-Q. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.12.010 · Cited by 128
“De Los Santos et al(29) 746 49 (20-86) T1-T4 IDC, ILC 3/1.”
Influential
Metadata
- Authors
- Shin, H. J., Baek, H., Ahn, J., Baek, S., Kim, H., Cha, J. H., & Kim, H. H.
- Venue
- NMR in Biomedicine
- Publisher
- Wiley
- Published
- 2012-05-06
- Volume
- 25
- Issue
- 12
- Pages
- 1349-1359
- ISSN
- 0952-3480 (ISSN-L)
- 1099-1492
- OpenAlex
- W1576402375
- Cited by
- 74
- References
- 1
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS. https://app.cochat.ai/papers/10.1002/nbm.2807
- The paper
- Shin, H. J., Baek, H., Ahn, J., Baek, S., Kim, H., Cha, J. H., & Kim, H. H. (2012). Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS. NMR in Biomedicine. https://doi.org/10.1002/nbm.2807
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.